У нас вы можете посмотреть бесплатно Palantir & HIMS: The Unseen Game-Changer! или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
👉 Learn Wall Street’s Secret Rules for Investors & Traders now: https://felixfriends.org/getfree 🚀 Get Our Market Beating Indicator for free for 7 Days: https://felixfriends.org/tradevision 👤 Meet Felix Prehn: I'm your host, Felix Prehn. My journey took me from being a novice investor to an investment banker, a corporate lawyer, and an entrepreneur. Investing was my key to early retirement at 40. My goal? To empower YOU to navigate the financial market with ease and transparency, free from the conventional financial system's noise. Let's embark on this journey to financial freedom together! ⚖️This is from my lovely lawyers: The content in this video is for informational and educational purposes only. It does not constitute and should not be construed as financial or investment advice or an offer to purchase or sell securities. The content is not personalized or tailored to a specific person or group of persons, nor to their personal investment or financial needs. You should consult a financial adviser or other investment professional authorized to provide investment advice. Investing comes with risks, including the risk of loss. Presentations of trades made by Felix Prehn or Goat Academy Ltd or its personnel are not a guarantee that any investment decision made by a student will be successful. Past performance is not a guarantee of future performance. Some of the accounts we highlight from time to time are our top performing accounts and the results shown are not typical. Trades shown may be from simulated trading or live trading accounts. *CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN Timestamps: 00:00 Intro 00:29 Key Takeaway: Exceptional Execution But Valuation Challenges Persist 01:08 Growth Drivers And Forward Guidance: Asymmetric Opportunities Identified 02:32 Investment Philosophy: Maximize Returns With Minimal Risk For Early Retirement 03:52 Customer Growth: 39% Increase And 139 Deals Over $1 Million Each 04:30 Raised Guidance: 36% Year-Over-Year Growth With Strong Execution 05:01 Palantir’s Premium Valuation: AI Leadership, Mission-Critical Software, And Rule Of 40 06:09 High Multiples Justified: Long-Term Growth Potential Vs. Speculative Froth 07:09 Growth Drivers: U.S. Commercial Expansion And Government Contracts 08:14 Palantir’s Edge: Ontology And Sustainable AI Differentiation 09:00 Challenges: 5% Decline In International Revenue And European Resistance To AI 10:01 Stock Chart Analysis: Overstretched Levels And Entry Point Strategy 11:46 Bullish Long-Term View: Palantir’s Path To Trillion-Dollar Valuation 12:26 HIMS And HERS: 111% Revenue Growth And 38% Subscriber Increase 13:30 Recurring Revenue: $84 Monthly Revenue Per Subscriber With Upselling Success 14:22 Vertical Integration: Fulfillment Centers And Personalized Treatments At Scale 15:50 Diversification: Growth In Dermatology, Mental Health, And Sexual Health 17:06 Future Growth Pillars: Personalization, High-Growth Specialties, And Longevity Medicine 18:11 Platform Power: AI Tools And Strategic Pharma Partnerships Like Novo Nordisk 19:09 Ambitious Guidance: $6.5 Billion Revenue Target By 2030 20:49 Oral Weight Loss Medications: High-Volume Offering With Competitive Pricing 22:17 Stock Price Challenges: High Expectations And Pre-Earnings Rally Impact 23:23 Outro #felixprehn #palantir #hims